FDA 483 - Tepha Incorporated - May 13, 2022

An FDA inspection of Tepha Incorporated in Lexington, MA, from May 11-13, 2022, identified one significant observation. The firm's procedures for corrective and preventive action were found to be inadequately established. Specifically, the effectiveness check for CAPA #1121 was deemed insufficient.